The Enterprise Value as of December 2025 (TTM) for Artiva Biotherapeutics, Inc. (ARTV) is 78.84M

According to Artiva Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 78.84M. This represents a change of -11.00% compared to the average of 88.58M of the last 4 quarters.

Artiva Biotherapeutics, Inc. (ARTV) Historical Enterprise Value (quarterly & annually)

How has ARTV Enterprise Value performed in the past?

The mean historical Enterprise Value of Artiva Biotherapeutics, Inc. over the last ten years is 137.69M. The current 78.84M Enterprise Value has changed 5.63% with respect to the historical average. Over the past ten years (40 quarters), ARTV's Enterprise Value was at its highest in in the September 2024 quarter at 334.32M. The Enterprise Value was at its lowest in in the March 2023 quarter at 0.

Artiva Biotherapeutics, Inc. (ARTV) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Artiva Biotherapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Artiva Biotherapeutics, Inc. (ARTV) Average Enterprise Value

How has ARTV Enterprise Value performed in the past?

The current Enterprise Value of Artiva Biotherapeutics, Inc. (ARTV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Artiva Biotherapeutics, Inc. (ARTV) Enterprise Value vs. Peers

How is ARTV’s Enterprise Value compared to its peers?

Artiva Biotherapeutics, Inc.’s Enterprise Value is greater than Precision BioSciences, Inc. (23.13M), less than Adverum Biotechnologies, Inc. (154.94M), greater than Sutro Biopharma, Inc. (31.59M), less than Fractyl Health, Inc. Common Stock (127.47M), greater than ALX Oncology Holdings Inc. (71.16M), greater than InflaRx N.V. (51.57M), less than Zentalis Pharmaceuticals, Inc. (101.24M), less than Metagenomi, Inc. Common Stock (83.35M), less than Connect Biopharma Holdings Limited (102.22M), less than Shattuck Labs, Inc. (101.48M),

Build a custom stock screener for Artiva Biotherapeutics, Inc. (ARTV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Artiva Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Artiva Biotherapeutics, Inc. (ARTV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Artiva Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.